当前位置: 首页 > 期刊 > 《中国当代医药》 > 2017年第8期 > 正文
编号:13064236
食管、胃双源癌外科治疗的研究进展(6)
http://www.100md.com 2017年3月15日 《中国当代医药》2017年第8期
     [25]Verbeke H,Geboes K,Van Damme J,et al.The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer[J].Biochim Biophys Acta,2012,1825(1):117-129.

    [26]Paslawski M,Zlomaniec J,Rucinska E,et al.Synchronous primary esophageal and gastric cancers[J].Ann Univ Mariae Curie Sklodowska Med,2004,59(1):406-410.

    [27]Miyazaki T,Sohda M,Higuchi T,et al.Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer[J].Anticancer Res,2014,34(1):283-287.

    [28]Chen SH,Chan SC,Chao YK,et al.Detection of sync?鄄hronous cancers by fluorodeoxyglucose positron emission tomography/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan[J].PLoS One,2013,8(11):e82812.

    [29]王德才,李俊杰,張长江.同时性食管及食管胃交界区重复癌的外科治疗[J].中国药物经济学,2014,9(2):285-286.

    [30]叶芃.贲门癌近端胃切除空肠间置术预防反流性食管炎[D].杭州:浙江大学,2005.

    [31]张伟.近端胃切除空肠间置在贲门癌手术中的应用[D].郑州:郑州大学,2013.

    [32]Honda M,Daiko H,Kinoshita T,et al.Minimally invasive resection of synchronous thoracic esophageal and gastric carcinomas followed by reconstruction:a case report[J].Surg Case Rep,2015,1(1):12.

    (收稿日期:2017-01-12 本文编辑:许俊琴) (梁健 黄杰 付印)
上一页1 2 3 4 5 6